Toshiba, which developed the diagnosis method with the
The method could be used to promote treatment of cancers from their early stage, it said.
The method is designed to examine the types and concentration of microRNA molecules secreted in blood from cancer cells.
"Compared to other companies' methods, we have an edge in the degree of accuracy in cancer detection, the time required for detection and the cost,"
The test will be used to detect gastric, esophageal, lung, liver, biliary tract, pancreatic, bowel, ovarian, prostate, bladder and breast cancers as well as sarcoma and glioma.
Toshiba has developed a chip and a small device that can conduct the diagnosis in less than two hours at a cost of
In its five-year business strategy starting
==Kyodo
© Kyodo News International, Inc., source